检索结果 - Hoog, Jeremy
- Showing 1 - 20 results of 37
- Go to Next Page
-
1
-
2
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER(+) breast cancer 由 Shee, Kevin, Jiang, Amanda, Varn, Frederick S., Liu, Stephanie, Traphagen, Nicole A., Owens, Philip, Ma, Cynthia X., Hoog, Jeremy, Cheng, Chao, Golub, Todd R., Straussman, Ravid, Miller, Todd W.
出版 2019Text -
3
-
4
Vav1/2/3-null Mice Define an Essential Role for Vav Family Proteins in Lymphocyte Development and Activation but a Differential Requirement in MAPK Signaling in T and B Cells 由 Fujikawa, Keiko, Miletic, Ana V., Alt, Frederick W., Faccio, Roberta, Brown, Tracie, Hoog, Jeremy, Fredericks, Jessica, Nishi, Shinzo, Mildiner, Shirly, Moores, Sheri L., Brugge, Joan, Rosen, Fred S., Swat, Wojciech
出版 2003Text -
5
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor Positive Metastatic Breast Cancer 由 Ma, Cynthia X., Sanchez, Cesar, Gao, Feng, Crowder, Robert, Naughton, Michael, Pluard, Timothy, Creekmore, Allison, Guo, Zhanfang, Hoog, Jeremy, Lockhart, A. Craig, Doyle, Laurence, Erlichman, Charles, Ellis, Matthew J.
出版 2016Text -
6
Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent 由 Marquez-Nostra, Bernadette V., Lee, Supum, Laforest, Richard, Vitale, Laura, Nie, Xingyu, Hyrc, Krzysztof, Keler, Tibor, Hawthorne, Thomas, Hoog, Jeremy, Li, Shunqiang, Dehdashti, Farrokh, Ma, Cynthia X., Lapi, Suzanne E.
出版 2017Text -
7
Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer 由 Hiken, Jeffrey F., McDonald, James I., Decker, Keith F., Sanchez, Cesar, Hoog, Jeremy, VanderKraats, Nathan D., Jung, Kyle L., Akinhanmi, Margaret, Rois, Lisa E., Ellis, Matthew J., Edwards, John R.
出版 2016Text -
8
Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models 由 Ma, Cynthia X., Cai, Shirong, Li, Shunqiang, Ryan, Christine E., Guo, Zhanfang, Schaiff, W. Timothy, Lin, Li, Hoog, Jeremy, Goiffon, Reece J., Prat, Aleix, Aft, Rebecca L., Ellis, Matthew J., Piwnica-Worms, Helen
出版 2012Text -
9
Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models 由 Ma, Cynthia X., Cai, Shirong, Li, Shunqiang, Ryan, Christine E., Guo, Zhanfang, Schaiff, W. Timothy, Lin, Li, Hoog, Jeremy, Goiffon, Reece J., Prat, Aleix, Aft, Rebecca L., Ellis, Matthew J., Piwnica-Worms, Helen
出版 2012Text -
10
Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer 由 Goncalves, Rodrigo, DeSchryver, Katherine, Ma, Cynthia, Tao, Yu, Hoog, Jeremy, Cheang, Maggie, Crouch, Erika, Dahiya, Neha, Sanati, Souzan, Barnes, Michael, Sarian, Luis Otávio Zanatta, Olson, John, Allred, Donald Craig, Ellis, Matthew J.
出版 2017Text -
11
Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1 由 Zhu, Cuige, Kim, Sun-Joong, Mooradian, Arshag, Wang, Faliang, Li, Ziqian, Holohan, Sean, Collins, Patrick L., Wang, Keren, Guo, Zhanfang, Hoog, Jeremy, Ma, Cynthia X., Oltz, Eugene M., Held, Jason M., Shao, Jieya
出版 2021Text -
12
Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models 由 Guo, Zhanfang, Primeau, Tina, Luo, Jingqin, Zhang, Cynthia, Sun, Hua, Hoog, Jeremy, Gao, Feng, Huang, Shixia, Edwards, Dean P., Davies, Sherri R., Aft, Rebecca, Ding, Li, Ellis, Matthew J., Li, Shunqiang, Ma, Cynthia X.
出版 2020Text -
13
Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women 由 Dunbier, Anita K., Anderson, Helen, Ghazoui, Zara, Folkerd, Elizabeth J., A'Hern, Roger, Crowder, Robert J., Hoog, Jeremy, Smith, Ian E., Osin, Peter, Nerurkar, Ashutosh, Parker, Joel S., Perou, Charles M., Ellis, Matthew J., Dowsett, Mitch
出版 2010Text -
14
An mRNA Gene Expression–Based Signature to Identify FGFR1-Amplified Estrogen Receptor–Positive Breast Tumors 由 Luo, Jingqin, Liu, Shuzhen, Leung, Samuel, Gru, Alejandro A., Tao, Yu, Hoog, Jeremy, Ho, Julie, Davies, Sherri R., Allred, D. Craig, Salavaggione, Andrea L., Snider, Jacqueline, Mardis, Elaine R., Nielsen, Torsten O., Ellis, Matthew J.
出版 2017Text -
15
Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib 由 Bagegni, Nusayba, Thomas, Shana, Liu, Ning, Luo, Jingqin, Hoog, Jeremy, Northfelt, Donald W., Goetz, Matthew P., Forero, Andres, Bergqvist, Mattias, Karen, Jakob, Neumüller, Magnus, Suh, Edward M., Guo, Zhanfang, Vij, Kiran, Sanati, Souzan, Ellis, Matthew, Ma, Cynthia X.
出版 2017Text -
16
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer 由 Ellis, Matthew J, Lin, Li, Crowder, Robert, Tao, Yu, Hoog, Jeremy, Snider, Jacqueline, Davies, Sherri, DeSchryver, Katherine, Evans, Dean B, Steinseifer, Jutta, Bandaru, Raj, Liu, WeiHua, Gardner, Humphrey, Semiglazov, Vladimir, Watson, Mark, Hunt, Kelly, Olson, John, Baselga, José
出版 2010Text -
17
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor positive breast cancer 由 Crowder, Robert J., Phommaly, Chanpheng, Tao, Yu, Hoog, Jeremy, Luo, Jingqin, Perou, Charles M., Parker, Joel S., Miller, Melinda A., Huntsman, David G., Lin, Li, Snider, Jacqueline, Davies, Sherri R., Olson, John A., Watson, Mark A., Saporita, Anthony, Weber, Jason D., Ellis, Matthew J.
出版 2009Text -
18
ESR1 gene amplification in breast cancer: a common phenomenon? 由 Brown, Lindsay A, Hoog, Jeremy, Chin, Suet-Feung, Tao, Yu, Zayed, Abd Alnaser, Chin, Koei, Teschendorff, Andrew E, Quackenbush, John F, Marioni, John C, Leung, Samuel, Perou, Charles M, Neilsen, Torsten O, Ellis, Matthew, Gray, Joe W, Bernard, Philip S, Huntsman, David G, Caldas, Carlos
出版 2008Text -
19
A phase 1 trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast cancer 由 Ma, Cynthia X., Luo, Jingqin, Naughton, Michael, Ademuyiwa, Foluso, Suresh, Rama, Griffith, Malachi, Griffith, Obi L., Skidmore, Zachary L., Spies, Nicholas C., Ramu, Avinash, Trani, Lee, Pluard, Timothy, Nagaraj, Gayathri, Thomas, Shana, Guo, Zhanfang, Hoog, Jeremy, Han, Jing, Mardis, Elaine, Lockhart, Craig, Ellis, Matthew J.
出版 2015Text -
20
Loss of MutL disrupts Chk2-dependent cell cycle control through CDK4/6 to promote intrinsic endocrine therapy resistance in primary breast cancer 由 Haricharan, Svasti, Punturi, Nindo, Singh, Purba, Holloway, Kimberly R., Anurag, Meenakshi, Schmelz, Jacob, Schmidt, Cheryl, Lei, Jonathan T., Suman, Vera, Hunt, Kelly, Olson, John A., Hoog, Jeremy, Li, Shunqiang, Huang, Shixia, Edwards, Dean P., Kavuri, Shyam M., Bainbridge, Matthew N., Ma, Cynthia X., Ellis, Matthew J.
出版 2017Text